NDRG2 and colorectal carcinoma: The subclassification also helps to define clinically which tumors are more likely to show certain already described molecular alterations, such as for example changes affecting NDRG2 or GAB2. Comparison with the consensus molecular classification also confirms the importance of considering both criteria when studying CRC.